BridgeMD
“Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”.
EU CTIS ID: 2024-519349-31-00
What this study is testing
Compare the efficacy of treatment with tranexamic acid (TXA) in patients with hip fracture, both in hospital admission (intravenously) and perioperatively (local and intravenous), and observe if this translates into a lower rate of blood transfusion.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Who is over 65 years of age, of both sexes. - Accept participation in the study (informed consent that will be signed by the patient or family member / legal representative depending on the degree of autonomy of the patient).
You likely can't join if
- In treatment with another experimental drug (not participating in another clinical trial with an experimental drug). - The refusal of the patient to participate in the study. - Known allergy to TXA. - Patients with a history of seizures. - Patients with severe kidney and liver failure.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.